Comparison of Methods to Improve Abdominal Aortic Aneurysm (AAA) Screening

Status Completed

Clinical Trial Summary

Standard of care dictates that eligible patients should receive an abdominal aortic aneurysm (AAA) screening ultrasound. At present, different military primary care physicians utilize different methods at their discretion to ensure their patients get screened—telephone contact; mail-out reminders; referring patients for ultrasound directly from an office visit; as well as other methods—which we will refer to as "usual care". The purpose of this study is to improve screening rates for AAA and determine what notification methods are best at improving screening rates.

Clinical Trial Description

Approximately 1700 male patients (DoD beneficiaries) between the ages of 65-75 will be selected from their medical records. The information on the attached abstracted data sheet will be collected. As part of standard patient care operations, the Family Medicine and Internal Medicine Departments will inform patients on the need to receive a AAA screening ultrasound, based on their primary care manager's (PCM) preference for clinical notification:

1. Nurse initiated Telephone Consult (T-Con) (see attached)

2. Mail-0ut Letter to the patient (see attached)

3. Provider, Nurse and Technician Education with point-of-care patient referrals , Exam Room Flyer

4. Control group (i.e. usual care)

The Provider, Nurse and Technician Education will consist of a presentation given by the Principal Investigator (see attached PowerPoint) to the Family Medicine and Internal Medicine clinic staff and the posting of Exam Room Flyers in each Family Medicine and Internal Medicine exam room to prompt and encourage patient referrals for a AAA screening ultrasound.

Information requested on the attached abstracted data sheet will be used for initial identification of patients that should have a AAA screening ultrasound and again 3-4 months later to see if these same individuals received the procedure. All informational data sets will be totally de-identified by the Research Coordinator, Nellis Air Force Base, prior to releasing to the Principle Investigator.

The data will then be analyzed by Dr. Anneke Bush (WHMC statistician) and the results will be provided to the Principal Investigator for analysis. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01301534
Study type	Observational
Source	Mike O'Callaghan Federal Hospital
Contact
Status	Completed
Phase	N/A
Start date	December 2010
Completion date	June 2012

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04227054` - Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks	N/A
Active, not recruiting	`NCT03687489` - Safety and Efficacy Study of Abdominal Aortic Aneurysm Stent Graft System	N/A
Active, not recruiting	`NCT03507413` - Metformin Therapy in Non-diabetic AAA Patients	Phase 2/Phase 3
Not yet recruiting	`NCT05756283` - The PREHAAAB Trial: Multimodal Prehabilitation for Patients Awaiting Open Abdominal Aortic Aneurysm Repair	N/A
Not yet recruiting	`NCT04089241` - Fusion of CT Angiography With 3D Contrast Ultrasound as a Method for Follow up for Endovascular Aneurysm Repair	N/A
Active, not recruiting	`NCT02604303` - A Prospective Analysis on the Expansion Rates of Abdominal Aortic Aneurysms
Terminated	`NCT02469376` - Evaluation of a New Imagingtechnologie for Thrombosis	Phase 1
Completed	`NCT02229006` - Sodium Fluoride Imaging of Abdominal Aortic Aneurysms	N/A
Completed	`NCT02224794` - LIFE Study: Least Invasive Fast-Track EVAR
Terminated	`NCT01843335` - Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair	N/A
Completed	`NCT01118520` - AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK)	Phase 2
Terminated	`NCT01425242` - Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension	N/A
Completed	`NCT00746122` - Immediate Management of the Patient With Rupture : Open Versus Endovascular Repair	N/A
Completed	`NCT03952780` - Korean Registry of Percutaneous EVAR With INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)
Completed	`NCT00583414` - Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients	N/A
Recruiting	`NCT05864560` - Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up
Completed	`NCT01683084` - Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms	Phase 4
Active, not recruiting	`NCT03180996` - Global Fenestrated Anaconda Clinical sTudy
Completed	`NCT02493296` - The Effect of Surgery on Central Aortic Pressure & haEmodynamics Study
Completed	`NCT03320408` - Predicting Aneurysm Growth and Rupture With Longitudinal Biomarkers

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Methods to Improve Abdominal Aortic Aneurysm (AAA) Screening Rates in the Primary Care Setting.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms